Status:
COMPLETED
SELESTIAL: Trial of Insulin to Control Blood Sugar After Acute Stroke Using Magnetic Resonance Imaging (MRI) End-Points
Lead Sponsor:
University of Glasgow
Collaborating Sponsors:
South Glasgow University Hospitals NHS Trust
The Stroke Association, United Kingdom
Conditions:
Acute Stroke
Hyperglycemia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
High blood sugar (hyperglycaemia) affects 40% of acute stroke patients and has a major adverse effect on survival and recovery. Increased production of lactic acid in brain tissue that has a poor bloo...
Detailed Description
Hyperglycaemia is present in 40-60% of patients with acute ischaemic stroke and adversely affects survival and outcome. This effect is independent of stroke severity or pathology, and is most striking...
Eligibility Criteria
Inclusion
- Acute stroke within 24h of onset
- Lesion on acute diffusion weighted MRI
- \>18 years age
Exclusion
- Coma
- Major concomitant illness limiting survival
Key Trial Info
Start Date :
May 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT00124826
Start Date
May 1 2004
Last Update
February 1 2006
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Neurological Sciences
Glasgow, United Kingdom, G51 4TF